Skip to main content

Instil Bio, Inc.

TIL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001789769

No open-market purchases or sales by Instil Bio, Inc. insiders were filed in the last 90 days; 26 institutions reported holding it in 13F filings for Q2 2026, worth $29.2M in total; no superinvestor holds it.

Q3 2024 vs. Q2 2024

How the institutions holding Instil Bio, Inc. changed between Q2 2024 and Q3 2024.

All holders in Q3 2024All holders in Q2 2024

13F holders of TIL: Q2 2024 compared with Q3 2024
MeasureQ2 2024Of which not filed for Q3 2024Q3 2024Change
Holders30149+20
Shares4.23M61.0K5.32M+1.15M (+27.6%)
Value$43.5M$627.9K$358.0M+$315.2M (+735.1%)

1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (28)

Institutions that held Instil Bio, Inc. at the end of Q3 2024 but not at the end of Q2 2024.

Institutions new to TIL in Q3 2024
InstitutionSharesValue% of portfolio
Boxer Capital, LLC355,500$23.9M1.17%
Perceptive Advisors LLC345,545$23.3M0.50%
Siren, L.L.C.192,433$13.0M0.65%
Commodore Capital LP150,929$10.2M0.63%
Invesco Ltd.145,118$9.77M0.00%
Superstring Capital Management LP107,545$7.24M6.47%
Point72 Asset Management, L.P.95,450$6.43M0.02%
BlackRock, Inc.52,794$3.55M0.00%
OrbiMed Advisors LLC33,700$2.27M0.04%
VR Adviser, LLC33,177$2.23M0.12%
Fred Alger Management, LLC31,332$2.11M0.01%
Avidity Partners Management LP29,100$1.96M0.10%
ADAR1 Capital Management, LLC23,707$1.60M0.27%
Balyasny Asset Management LLC17,222$1.16M0.00%
Palo Alto Investors LP11,165$751.6K0.10%
HRT Financial LP10,902$733.0K0.00%
Silverarc Capital Management, LLC10,517$708.0K0.16%
Dimensional Fund Advisors LP9,953$670.0K0.00%
Northern Trust Corp7,103$478.2K0.00%
Squarepoint Ops LLC5,374$361.8K0.00%
Beacon Pointe Advisors, LLC4,849$326.4K0.00%
Omers Administration Corp3,800$255.8K0.00%
XTX Topco Ltd3,605$242.7K0.02%
Virtu Financial LLC3,335$224.0K0.01%
FORA Capital, LLC3,085$207.7K0.02%
Charles Schwab Investment Management Inc2,981$200.7K0.00%
JPMorgan Chase & Co2,332$157.0K0.00%
Bokf, NA354$18.5K0.00%

Sold out (8)

Institutions that held Instil Bio, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.

Institutions that sold out of TIL in Q3 2024
InstitutionShares, Q2 2024Value, Q2 2024
Cable Car Capital LLC258,097$2.66M
Millennium Management LLC31,631$325.5K
Two Sigma Advisers, LP28,089$289.0K
Two Sigma Investments, LP23,790$244.8K
Acadian Asset Management LLC10,244$104.0K
Northwestern Mutual Wealth Management Co625$6.43K
Royal Bank of Canada171$2.00K
Qube Research & Technologies Ltd1$10

Not filed for Q3 2024 yet (1)

Institutions that held Instil Bio, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding TIL in Q2 2024 that haven't filed for Q3 2024
InstitutionShares, Q2 2024Value, Q2 2024
BlackRock Inc.61,019$627.9K